v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ (295,571) $ (429,952)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 67,605 48,804
Non-cash operating lease costs 17,882 17,842
Amortization of deferred commissions 57,730 25,796
Stock-based compensation, net of any amounts capitalized 402,470 379,460
Net accretion of discounts on investments (2,205) (7,652)
Net realized and unrealized losses on strategic investments 9,498 29,685
Amortization of debt issuance costs 2,080 2,071
Asset impairment related to office facility exits 17,724 106,488
Deferred income tax (6,562) 0
Other 2,821 (5,174)
Changes in operating assets and liabilities, net of effects of a business combination:    
Accounts receivable 747,217 393,657
Deferred commissions (36,799) (31,114)
Prepaid expenses and other assets (22,455) (17,852)
Accounts payable (89,673) (4,423)
Accrued expenses and other liabilities (80,791) 3,935
Operating lease liabilities (19,207) (11,838)
Deferred revenue (528,541) (271,360)
Net cash provided by operating activities 243,223 228,373
Cash flows from investing activities:    
Purchases of property and equipment (10,451) (44,989)
Cash paid for a business combination, net of cash, cash equivalents and restricted cash acquired (252,457) 0
Purchases of investments (896,447) (1,012,575)
Sales of investments 109,694 17,399
Maturities and redemptions of investments 445,170 984,182
Net cash used in investing activities (604,491) (55,983)
Cash flows from financing activities:    
Proceeds from exercise of stock options 6,579 6,260
Proceeds from issuance of common stock under employee stock purchase plan 66,987 53,193
Taxes paid related to net share settlement of equity awards (142,846) (132,498)
Repurchases of common stock (300,003) (490,638)
Payments of deferred purchase consideration for business combinations (2,250) (374)
Net cash used in financing activities (371,533) (564,057)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (2,824) 12,397
Net decrease in cash, cash equivalents, and restricted cash (735,625) (379,270)
Cash, cash equivalents, and restricted cash—beginning of period 2,864,303 2,698,678
Cash, cash equivalents, and restricted cash—end of period 2,128,678 2,319,408
Supplemental disclosures of non-cash investing and financing activities:    
Property and equipment included in accounts payable and accrued expenses 14,914 32,184
Non-cash consideration for a business combination 310,068 0
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 2,084,715 2,243,083
Restricted cash—included in other assets and prepaid expenses and other current assets 43,963 76,325
Total cash, cash equivalents, and restricted cash $ 2,128,678 $ 2,319,408